Vista Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Sell |
1,614
-40
| -2% | -$17.8K | 0.27% | 103 |
|
|
2025
Q1 | $802K | Sell |
1,654
-18
| -1% | -$8.73K | 0.31% | 93 |
|
|
2024
Q4 | $673K | Buy |
1,672
+20
| +1% | +$8.05K | 0.26% | 104 |
|
|
2024
Q3 | $768K | Sell |
1,652
-20
| -1% | -$9.3K | 0.29% | 99 |
|
|
2024
Q2 | $784K | Sell |
1,672
-28
| -2% | -$13.1K | 0.32% | 91 |
|
|
2024
Q1 | $711K | Sell |
1,700
-53
| -3% | -$22.2K | 0.29% | 98 |
|
|
2023
Q4 | $713K | Buy |
1,753
+1
| +0.1% | +$407 | 0.33% | 95 |
|
|
2023
Q3 | $609K | Sell |
1,752
-24
| -1% | -$8.35K | 0.32% | 99 |
|
|
2023
Q2 | $625K | Sell |
1,776
-110
| -6% | -$38.7K | 0.32% | 102 |
|
|
2023
Q1 | $594K | Buy |
1,886
+38
| +2% | +$12K | 0.31% | 101 |
|
|
2022
Q4 | $534K | Sell |
1,848
-9
| -0.5% | -$2.6K | 0.3% | 101 |
|
|
2022
Q3 | $538K | Sell |
1,857
-19
| -1% | -$5.51K | 0.33% | 95 |
|
|
2022
Q2 | $529K | Sell |
1,876
-22
| -1% | -$6.2K | 0.32% | 96 |
|
|
2022
Q1 | $495K | Sell |
1,898
-4
| -0.2% | -$1.04K | 0.27% | 101 |
|
|
2021
Q4 | $418K | Sell |
1,902
-26
| -1% | -$5.71K | 0.23% | 107 |
|
|
2021
Q3 | $350K | Buy |
1,928
+271
| +16% | +$49.2K | 0.21% | 118 |
|
|
2021
Q2 | $334K | Buy |
+1,657
| New | +$334K | 0.2% | 124 |
|